Radiopharm Theranostics Ltd (RADX) stock
RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 6/30
$0.67−0.10 (-12.58%)
Close on Nov 17, 2026Market cap $7.93MP/E –Yield –
Radiopharm Theranostics gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2026 it was 9.5%, against 1.1% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | 9.5% | +8.4 |
| FY2025 | Jun 30, 2025 | 1.1% | −98.9 |
| FY2024 | Jun 30, 2024 | 100.0% | +0.0 |
| FY2023 | Jun 30, 2023 | 100.0% | – |
See a number that looks wrong?